Search research articles
Contact Us
Filters
Showing results (101-110 of 127) with videos related to
Page
of 13
Sort By:
Fundamental & Clinical Pharmacology
|
May 19, 2011
A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease
Olivier Rascol, Joaquim Ferreira, Laurence Nègre-Pages, et al.
Journal of Neuroscience Methods
|
March 1, 2011
Generation of a model of L-DOPA-induced dyskinesia in two different mouse strains
Sherri L Thiele, Ruth Warre, Charline S Khademullah, et al.
Journal of Neurophysiology
|
October 19, 2012
Deep brain stimulation of the substantia nigra pars reticulata improves forelimb akinesia in the hemiparkinsonian rat
Alexander C Sutton, Wilson Yu, Megan E Calos, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 23, 2010
Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease
Tom H Johnston, Philippe Huot, Susan H Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 9, 2018
Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia
Elizabeth F Brigham, Tom H Johnston, Carl Brown, et al.
The European Journal of Neuroscience
|
November 6, 2012
Elevated potassium provides an ionic mechanism for deep brain stimulation in the hemiparkinsonian rat
Alexander C Sutton, Wilson Yu, Megan E Calos, et al.
Neuropharmacology
|
February 27, 2024
Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesia
Tom H Johnston, Alix M B Lacoste, Paula Ravenscroft, et al.
Experimental Neurology
|
January 28, 2015
Gap junction blockers attenuate beta oscillations and improve forelimb function in hemiparkinsonian rats
Sujoy Phookan, Alexander C Sutton, Ian Walling, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 22, 2015
Management of impulse control disorders in Parkinson's disease: Controversies and future approaches
Michael Samuel, Maria Rodriguez-Oroz, Angelo Antonini, et al.
Journal of Neurochemistry
|
April 16, 2008
Striatal histone modifications in models of levodopa-induced dyskinesia
Anthony P Nicholas, Farah D Lubin, Penelope J Hallett, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 127) with videos related to
Sort By:
Page
of 13
Fundamental & Clinical Pharmacology
|
May 19, 2011
A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease
Olivier Rascol, Joaquim Ferreira, Laurence Nègre-Pages, et al.
Journal of Neuroscience Methods
|
March 1, 2011
Generation of a model of L-DOPA-induced dyskinesia in two different mouse strains
Sherri L Thiele, Ruth Warre, Charline S Khademullah, et al.
Journal of Neurophysiology
|
October 19, 2012
Deep brain stimulation of the substantia nigra pars reticulata improves forelimb akinesia in the hemiparkinsonian rat
Alexander C Sutton, Wilson Yu, Megan E Calos, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 23, 2010
Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease
Tom H Johnston, Philippe Huot, Susan H Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 9, 2018
Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia
Elizabeth F Brigham, Tom H Johnston, Carl Brown, et al.
The European Journal of Neuroscience
|
November 6, 2012
Elevated potassium provides an ionic mechanism for deep brain stimulation in the hemiparkinsonian rat
Alexander C Sutton, Wilson Yu, Megan E Calos, et al.
Neuropharmacology
|
February 27, 2024
Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesia
Tom H Johnston, Alix M B Lacoste, Paula Ravenscroft, et al.
Experimental Neurology
|
January 28, 2015
Gap junction blockers attenuate beta oscillations and improve forelimb function in hemiparkinsonian rats
Sujoy Phookan, Alexander C Sutton, Ian Walling, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 22, 2015
Management of impulse control disorders in Parkinson's disease: Controversies and future approaches
Michael Samuel, Maria Rodriguez-Oroz, Angelo Antonini, et al.
Journal of Neurochemistry
|
April 16, 2008
Striatal histone modifications in models of levodopa-induced dyskinesia
Anthony P Nicholas, Farah D Lubin, Penelope J Hallett, et al.
Page
of 13